Evidence map›Paper›PMID 37990053›Full record

ArticleScientific reports2023

Phosphodiesterase 4 inhibition after retrieval switches the memory fate favoring extinction instead of reconsolidation.

Jeferson Machado Batista Sohn, Nathalie Carla Cardoso, Ana Maria Raymundi, Jos Prickaerts, Cristina Aparecida Jark Stern

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jeferson Machado Batista SohnDepartment of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil.
Nathalie Carla CardosoDepartment of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil.
Ana Maria RaymundiDepartment of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil.
Jos PrickaertsDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, University of Maastricht, Maastricht, The Netherlands.
Cristina Aparecida Jark SternDepartment of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil. cristinastern.cs@gmail.com.
Universidade Federal do Paraná · BRMaastricht University · NL

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 309111/2022-6Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES/NUFFIC 2017/07
6 · The paper itself

Abstract

Phosphodiesterase 4 (PDE4), an enzyme expressed in the dorsal hippocampus (DH), hydrolyzes the cAMP, limiting the PKA-induced CREB phosphorylation (pCREB) and BDNF expression. Depending on the brain region, PKA and pCREB mediate reconsolidation or extinction, whereas BDNF is mainly related to extinction facilitation. The mechanisms underpinning the switch between reconsolidation and extinction are relatively unknown. Here, we tested the hypothesis that PDE4 might control these processes. We showed in Wistar rats submitted to contextual fear conditioning that PDE4 inhibition with roflumilast (ROF) within the DH, after a short retrieval, did not change freezing behavior after one day (TestA

Indexed as

Cyclic Nucleotide Phosphodiesterases, Type 4MemoryAnimalsBrain-Derived Neurotrophic FactorExtinction, PsychologicalHippocampusRatsRats, WistarBrain-Derived Neurotrophic FactorCyclic Nucleotide Phosphodiesterases, Type 4

Identifiers

PMID37990053
PMCPMC10663466
OpenAlexW4388854195

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.